CLLS NASDAQ
Cellectis S.A.
1W: -2.7%
1M: -56.0%
3M: -56.5%
YTD: -70.2%
1Y: -56.5%
3Y: -10.6%
5Y: -89.3%
$1.43
+0.03 (+2.14%)
Weekly Expected Move ±23.0%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$73M
+76.3% ▲
5Y CAGR: +7.5%
Gross Profit
$53M
+64.1% ▲
5Y CAGR: +1.6%
Operating Income
-$40M
+32.0% ▲
Net Income
-$68M
-84.4% ▼
EPS (Diluted)
$-0.68
-65.9% ▼
EBITDA
-$20M
-115.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $30M | $19M | $755K | $42M | $73M |
| YoY Growth | -40.6% | -36.8% | -96.1% | +5397.5% | +76.3% |
| Cost of Revenue | $2M | $8M | $7M | $9M | $20M |
| Gross Profit | $29M | $11M | -$7M | $32M | $53M |
| Gross Margin | 93.9% | 55.7% | -882.6% | 77.9% | 72.5% |
| R&D Expenses | $118M | $98M | $88M | $91M | $94M |
| SG&A Expenses | $23M | $9M | $8M | $8M | $20M |
| Operating Expenses | $132M | $100M | $91M | $92M | $94M |
| Operating Income | -$103M | -$90M | -$97M | -$60M | -$40M |
| Operating Margin | -341.0% | -467.7% | -12887.7% | -143.5% | -55.3% |
| Interest Expense | $4M | $4M | $5M | $7M | $8M |
| Income Before Tax | -$97M | -$99M | -$116M | -$37M | -$75M |
| Tax Expense | -$3K | $87K | $371K | $0 | -$7M |
| Net Income | -$114M | -$106M | -$101M | -$37M | -$68M |
| Net Margin | -376.3% | -553.6% | -13385.3% | -88.6% | -92.7% |
| EPS (Diluted) | $-1.93 | $-2.33 | $-1.77 | $-0.41 | $-0.68 |
| EBITDA | -$78M | -$76M | -$93M | -$9M | -$20M |
| Shares Outstanding | 45M | 46M | 57M | 91M | 100M |